Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Go back to Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis
(NASDAQ: ACON) Delayed: 2.34 +0.03 (1.30%)
Previous Close $2.31    52 Week High $ 
Open $2.32    52 Week Low $ 
Day High $2.37    P/E N/A 
Day Low $2.32    EPS $ 
Volume 7,298       

(NASDAQ: ACONW) Delayed: 0.02 --0 (-0%)
Previous Close $0.02    52 Week High $ 
Open $0.02    52 Week Low $ 
Day High $0.02    P/E N/A 
Day Low $0.02    EPS $ 
Volume 12